Handling of Ridout Road bungalow rentals shows Govt's commitment to incorruptibility, says PM Lee who retains 'full confidence' in cleared ministers

-
#trending: GrabFood rider banned for throwing customer's order on ground; netizens slam act as 'rude' and 'barbaric'

Entradas populares de este blog

Breaking news: F.D.A. approves weight loss drug to treat obstructive sleep apnea

-
Imagen
Zepbound is the first prescription drug approved specifically to treat the common condition. View in browser Dec. 20, 2024, 5:22 p.m. ET BREAKING NEWS Dustin Chambers for The New York Times F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder. Read more Need help? Review our newsletter help page or contact us for assistance. You received this email because you signed up for Breaking News from The New York Times. To stop receiving Breaking News, unsubscribe . To opt out of other promotional emails from The Times, including those regarding The Athletic, manage your email settings . To opt out of updates and offers sent from The Athletic, submit a request . Subscribe to The Times Get The New York Times app Connect with us on: Change Your Email Privacy Policy Contact Us Califo...
Leer más

Dozens in their town developed a mysterious brain disease. No one knows why.

-
Imagen
The scientific puzzle has now become a political maelstrom. View in browser | nytimes.com August 19, 2024 Doctors identified a cluster of patients in the Canadian province of New Brunswick with similar brain diseases. Laurie Beatty is one of many local residents who have exhibited comparable, inexplicable symptoms of neurological decline. Brendan George Ko for The New York Times In the absence of answers, a political maelstrom has ensued. → Sign up for The New York Times Magazine newsletter. Get the best of each issue with cover stories, long reads and columns like Talk, Diagnosis and Eat. Get it in your inbox Need help? Review our newsletter help page or contact us for assistance. You received this message because you signed up for updates from The New York Times. To stop receiving From The Times, unsubscribe . To opt out of other promotional emails from The Times, including those regarding The Athletic, manage your email settings . To opt out of updates and offers sent from The ...
Leer más